CAREGEN CO.,LTD. Logo

CAREGEN CO.,LTD.

Develops biomimetic peptides and growth factors for aesthetic and medical solutions.

214370 | KO

Overview

Corporate Details

ISIN(s):
KR7214370009
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 엘에스로91번길 46-38, 안양시

Description

Caregen Co., Ltd. is a global biotechnology company specializing in the research, development, and commercialization of biomimetic peptides and growth factors. As a leader in peptide synthesis, the company leverages its world-class, patented technologies to create innovative products. Its portfolio provides comprehensive solutions for the anti-aging, aesthetic, and cosmeceutical sectors, with applications targeting skin pigmentation, inflammation, hair care, and weight management. The company's research focuses on developing peptide-based therapeutics and total health care solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
주주총회소집공고
Korean 54.0 KB
2025-09-08 00:00
의결권대리행사권유참고서류
Korean 38.5 KB
2025-08-18 00:00
[기재정정]주주총회소집결의 (임시주주총회)
Korean 11.1 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-12 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.9 KB
2025-08-12 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2025-08-12 00:00
주주총회소집결의 (임시주주총회)
Korean 6.3 KB
2025-07-15 00:00
[기재정정]기업설명회(IR)개최
Korean 10.6 KB
2025-07-11 00:00
기업설명회(IR)개최
Korean 7.0 KB
2025-07-04 00:00
현금ㆍ현물배당결정 (중간배당)
Korean 8.6 KB
2025-06-26 00:00
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (CGP5 펩타이드 기반 신약 후보물질의 제1상 임상시험계…
Korean 25.2 KB
2025-06-13 00:00
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.7 KB
2025-05-21 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-13 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.9 KB
2025-05-13 00:00
분기보고서 (2025.03)
Korean 1.3 MB

Automate Your Workflow. Get a real-time feed of all CAREGEN CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAREGEN CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAREGEN CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.